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Autoimmune hemolytic anemia
caused by warm-reacting IgM-class
antibodies
R.J. SOKOL, D.J. BOOKER, R. STAMPS, S. Sobolewski, and A. P. Haynes
Warm IgM autoantibodies occur in association with IgG-class and/or
IgA-class immunoglobulins in approximately 30 percent of patients
with warm-type autoimmune hemolysis. They may be classified as
agglutinins or hemolysins, which may be incomplete or complete,
depending on in vitro serology; they almost always bind comple-
ment. Autoimmune hemolytic anemia solely due to warm IgM
autoantibodies is exceedingly rare. We report two cases of the
incomplete agglutinin type. The autoantibodies were confirmed as
IgM by their ability to rebind to normal red blood cells (RBCs) after
elution; the absence of small increases in RBC-bound IgG and IgA
was shown by a sensitive enzyme-linked antiglobulin test. Patient 1
was a 64-year-old female with non-Hodgkin’s lymphoma, with a
hemoglobin of 50 g/L and haptoglobin of < 0.1 g/L. Direct antiglob-
ulin tests were positive for IgM, C3d, and C3c; only IgM was present
in an eluate. The serum contained a weak autoantibody at 37°C and
tests for hemolysins were negative. The patient suffered chronic
hemolysis and required intensive treatment, including splenectomy.
Patient 2 was a 65-year-old female; the hemoglobin was 78 g/L and
the haptoglobin was < 0.1 g/L. Direct antiglobulin tests were positive
for IgM and C3d; an eluate contained only IgM. No free autoantibody
was present in the serum and tests for hemolysins were negative.
Two serious infections occurred and the hemolysis remained chron-
ic, requiring continuous treatment during the 4 months she was 
followed. Immunohematology 1998;14:53–58.
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Red blood cell (RBC) autoantibodies of the IgM class
can be found in approximately 30 percent of patients
with warm-type autoimmune hemolysis if sensitive
direct antiglobulin techniques are used; these autoanti-
bodies almost always occur in association with antibod-
ies of the IgG and/or IgA class.1 Patients in whom
autoimmune hemolytic anemia (AIHA) is solely due to
warm-reacting IgM antibodies are exceeding rare. We
report two such cases; the autoantibody nature of the
two IgM antibodies was confirmed by their ability to
rebind to normal RBCs after elution;the absence of small
increases in RBC-bound IgG and IgA was shown by a
sensitive enzyme-linked antiglobulin test.
Case Reports
Patient 1 was a 64-year-old female who presented
with a short history of increasing weakness and fatigue.
Physical examination revealed gross pallor, mild icterus,
hepatomegaly (4 cm below right costal margin),
splenomegaly (10 cm below left costal margin), tachy-
cardia, and an ejection systolic murmur.The hemoglobin
level was 50 g/L and RBC, reticulocyte, leukocyte, and
platelet counts were 1.4 × 1012/L, 120 × 109/L, 1.2 ×
109/L, and 100 × 109/L, respectively.The bone marrow
showed marked erythroid hyperplasia and a few small
densely stained lymphocytes; a trephine biopsy con-
firmed a diagnosis of non-Hodgkin’s lymphoma of the
centrocytic-centroblastic type.The serum bilirubin level
was 32μmol/L (normal, ≤ 17 μmol/L) and the hap-
toglobin was < 0.1 g/L.The direct antiglobulin test (DAT)
was positive for IgM, C3d, and C3c.A diagnosis of warm-
type AIHA secondary to malignant lymphoma was made.
Pulsed combination chemotherapy (cyclophosphamide,
vincristine, adriamycin, and prednisolone) was started
and blood transfusion support was given. The patient
responded well, her general condition gradually
improved, and the splenomegaly decreased; transfusions
were no longer needed after 6 months,although the DAT
remained positive for IgM and C3d. Eighteen months
after presentation, she complained of a decline in her
general health and progressive weakness and lethargy.
These symptoms were due to a relapse of the AIHA:
hemoglobin 79 g/L, reticulocyte count 211 × 109/L,
serum bilirubin 41 μmol/L, haptoglobin < 0.1 g/L, and
strongly positive DAT for IgM, C3d, and C3c.Treatment
with high-dose steroids, intravenous immunoglobulin,
and blood transfusion was instituted, and subsequent
splenic irradiation was given; splenectomy was eventu-
ally performed at 23 months.The pulsed chemotherapy
continued and the patient slowly recovered. She was
reasonably well when last seen 39 months after presen-
tation; her blood counts were normal, but the DAT was
still positive for C3d.
Patient 2 was a 65-year-old female who presented
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with a 2-month history of anemia. There had been no
symptoms suggestive of cardiovascular or lymphoprolif-
erative disease or of malignancy. Physical examination
revealed pallor and a degree of icterus but was other-
wise unremarkable. The hemoglobin level was 78 g/L
and reticulocytes were 244 × 109/L.The blood film was
consistent with hemolytic anemia, showing spherocytes
and polychromasia; bone marrow aspiration confirmed
erythroid hyperplasia but revealed no other pathology.
The serum levels of bilirubin, lactic dehydrogenase, and
haptoglobin were 50 μmol/L,733 IU/L (normal:230–460
IU/L) and < 0.1 g/L, respectively.The DAT was strongly
positive for IgM and C3d.A diagnosis of idiopathic warm-
type AIHA was made and treatment with prednisolone
(40 mg/day) was started.The initial response was good
and the hemoglobin level rose significantly over 2
weeks. However, an attempt to reduce the dose of pred-
nisolone was unsuccessful and azathioprine (100 mg
daily) was added to the treatment regime. One month
after presentation, she was readmitted to the hospital
with a hyperosmolar nonketotic diabetic coma associat-
ed with a Salmonella septicemia and she required treat-
ment with insulin and intravenous antibiotics; blood
transfusion also was necessary as the hemoglobin level
had fallen to 61 g/L. Three weeks later she was again
admitted, on this occasion suffering from pneumonia,
and was once more treated with intravenous antibiotics;
blood transfusion also was given even though the
hemolytic anemia appeared to be well controlled with
continued treatment. Further blood transfusions were
given 2 and 6 weeks after this episode, but the patient
became lost to follow-up thereafter and apparently died
at home within a short period. Details of the cause of
death were not available.
Materials and Methods
The immunohematologic investigations carried out at
this Centre have been described elsewhere.2–5The DATs
employed standard agglutination and enzyme-linked
methods, both techniques using heavy chain-specific
anti-human IgG, -IgA, and -IgM; the agglutination method
also used anti-human C3d and -C3c. The agglutinating
reagents were produced at this Centre by immunizing
rabbits with purified human serum protein (e.g., IgM),
and made specific by selective absorption.The enzyme-
linked reagents were obtained commercially (Sigma
Biosciences, Poole, UK); this assay was extremely sensi-
tive and could measure the small amounts of
immunoglobulins on normal RBCs and, in the case of
IgG, the results in absorbance units could be converted
to molecules per cell. 3 Indirect antiglobulin tests (IATs)
were used to examine the autoantibodies in the serum
and in eluates prepared by standard heat and acid meth-
ods.5,6 Tests for warm and cold hemolysins were carried
out as described previously and involved the use of acid-
ified serum at 18°C and 37°C, papainized RBCs at 37°C,
and the indirect Donath Landsteiner procedure.5 Serum
haptoglobin levels were measured by their hemoglobin
binding capacity7 (normal range: 0.4–2.0 g/L).
Results
Patient 1 was group A, D+.The standard agglutination
DAT was strongly positive for IgM, C3d, and C3c, and
negative for IgG and IgA. The enzyme-linked DAT was
strongly positive for IgM and negative for IgG and IgA; it
showed that the amount of cell-bound IgG was, in fact,
reduced (< 10 mols/red cell).The RBC eluate contained
autoantibody of the IgM class only,and showed no speci-
ficity within the routinely identified blood group sys-
tems (ABO, Rh, Kell, MNS, Duffy, and Kidd).A weak IgM-
class autoantibody with stronger reactions against autol-
ogous red cells was identified in the serum using a LISS
IAT.Tests for warm and cold hemolysins were negative.
This serologic pattern remained virtually unchanged
throughout the course of her illness and was still evident
when the AIHA relapsed 18 months after presentation.
Patient 2 was group A, D+.The standard agglutination
DAT was positive for IgM and C3d and negative for IgG
and IgA.The enzyme-linked test was strongly positive for
IgM, whereas the level of cell-bound IgG (< 10 mols/red
cell) was reduced. Autoantibody of the IgM class only
was eluted from the RBCs; it showed no evidence of rou-
tine specificity. The IAT employing LISS demonstrated
that no free autoantibodies were present in the serum.
Tests for warm and cold hemolysins were negative.The
serologic pattern was similar in tests carried out 1 and 2
months after presentation, but at 3 months, the enzyme-
linked DAT showed weak positive results for IgG and IgA
(in addition to the strong IgM), the IgG being detected
by the agglutination method at 4 months.These changes
were accompanied by the development of a weakly
reacting serum autoantibody; the haptoglobin levels
remained normal during this period.
Discussion
Patients with warm IgM autoantibodies as the sole
immunoglobulin bound to their RBCs are exceedingly
rare and account for well below 1 percent of cases with
AIHA. 1,2,8–10 These autoantibodies are, however, more
commonly seen in association with autoantibodies of
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other immunoglobulin classes, in which quoted inci-
dences range from approximately 2–8 percent using
conventional DATs8-11 to about 30 percent if sensitive
enzyme-linked methods are employed,1 and as such are
more frequent than warm autoantibodies of the IgA
class.1,12 Because warm IgM autoantibodies are rare,
their literature tends to be biased toward interesting and
spectacular cases;this should be kept in mind when con-
sidering, for example, details of age, sex-associated dis-
eases, and clinical manifestations. Particularly interesting
cases also may be featured in more than one arti-
cle.11,13,14
Our patients were both female and in their middle
60s, which is in keeping with previous reports in adults
of 16 females and 12 males,age 22–78 years (median age
57 years) and 15–78 years (median age 58 years), respec-
tively. 13,15–25 In the one published series of warm IgM
autoantibodies in children, there were 7 females and 5
males, and their ages ranged from 2 days to 6 years.26
In Patient 1, the condition was secondary to non-
Hodgkin’s lymphoma,whereas Patient 2’s condition was
idiopathic. A number of the previous cases also were
secondary to a variety of diseases, including non-
Hodgkin’s lymphoma,20,25,27,28 Hodgkin’s disease,11
chronic myeloid leukemia,11 primary biliary cirrhosis,11
systemic lupus erythematosus,11,17 polyarthritis,24
rheumatoid arthritis,19 collagen vascular disease,20 infec-
tion,20,26 and methyl dopa therapy;16 whereas in others,
the condition was idiopathic.11,15,20,21,25
The autoantibodies in our cases were predominantly
cell bound and showed no obvious specificity within the
routinely identified blood group systems; however, it
should be noted that they were not tested for sialidase-
sensitive determinants (anti-Ena, Pr, Wrb, or Ge), which
have been particularly associated with warm-reacting
IgM-class autoantibodies and severe, sometimes fatal,
hemolysis.10,18,23,25,27 Other reported specificities have
included anti-c,22 anti-e,19 anti-H,28 anti-I,11 and anti-IT.15
Warm IgM autoantibodies almost always bind com-
plement, as in Patients 1 and 2, and can be conveniently
classified by their in vitro serologic reactions into agglu-
tinins and hemolysins, which may be either incomplete
or complete.9,12,29,30
The present patients can be placed in the incomplete
agglutinin group in which the IgM autoantibodies are
detected by antiglobulin techniques. RBC destruction is
most often extravascular and takes place mainly in the
liver via macrophage complement receptors.There are
few reported cases in this category,18,22,25,31 and the
severity of the hemolysis in Patients 1 and 2,as judged by
the nadir of hemoglobin levels (50 and 78 g/L), was sim-
ilar to the 48–71 g/L in the other cases.18,25 The clinical
course has varied dramatically and includes examples of
transient hemolysis responding well to treatment,22
acute fulminating and rapidly fatal hemolysis,18,25 and
chronic hemolysis, which is difficult to treat, as in our
patients. It should be recalled that Patient 2 died within
a few months of presentation.
Complete agglutinins11,15,19,23,24,28,31,32 agglutinate
the patient’s RBCs in saline and give rise to severe
hemolysis, with hemoglobin levels ranging from 33 g/L
to 72 g/L.11,15,19,24,28 The response to treatment has var-
ied; some patients experience a good recovery with
steroids,11,15,19 whereas others experience a rapidly fatal
hemolysis that was refractory to intensive treat-
ment.11,15,28,32
The vast majority of warm IgM hemolysins fall into
the incomplete group; these react only with enzyme-
treated RBCs in vitro.20,33 They frequently occur in asso-
ciation with autoantibodies of other immunoglobulin
classes (mostly IgG), being detected in 259 out of 1,999
cases (13%) with warm autoantibodies30 and in 18 out of
340 patients (5.3%) with warm-type autoimmune hemol-
ysis.2 Clinically, incomplete hemolysins are relatively
benign and only occasionally are associated with mod-
erate hemolysis in vivo.30 If treatment is required,
steroids and blood transfusions are usually effective.
However, in some patients with complicated clinical his-
tories, fatalities have occurred and were associated with
severe hemolysis and hemoglobin levels as low as 46
g/L.20
Complete hemolysins lyse nonenzyme-treated RBCs
in vitro and are typically associated with severe intravas-
cular hemolysis;30 this may be fatal,10 sometimes within
24 hours of diagnosis.21 Fortunately, these antibodies are
rare, with only 4 out of 340 examples of warm
hemolysins reacting with untreated RBCs.9 Hemoglobin
levels are typically low (e.g., < 50 g/L),21 and patient
treatment, based on blood transfusion and high-dose
steroids, can be difficult,30 although sometimes a good
response has been reported;27 plasma exchange and
complement inhibitory agents have been suggested on
theoretical grounds.30 Occasional cases may have a
more benign prognosis and two patients in which the in
vitro hemolytic activity was ionic-strength dependent
had no evidence of hemolysis in vivo.27
Some patients do not fit into these groups and a series
of children were described with warm IgM RBC autoan-
tibodies that were nonagglutinating and noncomple-
ment binding.26 Hemolysis was generally severe
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(hemoglobin levels ranging from 30–94 g/L), but tended
to respond well to steroids and blood transfusions.26
How these IgM autoantibodies caused RBC destruction
(other than by the undetected activation of comple-
ment) is not known,as macrophages are said to lack spe-
cific receptors for IgM.34 However, in other circum-
stances, evidence has been presented that IgM coating
can act synergistically with IgG in promoting RBC
destruction independently of complement.1,35 In a study
using strictly defined population groups with no
detectable RBC-bound complement, a significantly high-
er proportion of patients with small amounts of IgM in
addition to IgG on their RBCs had haptoglobins of < 0.1
g/L compared with patients with IgG alone on their cells
(p < .0005).1,35
The autoantibody nature of the cell-bound IgM in the
present patients was shown by the elution studies
whereby the IgM could be rebound onto normal RBCs
and detected by an indirect antiglobulin technique; this
rebinding distinguishes it from immunoglobulin
attached to the red cells as part of an immune complex
or from nonspecific adsorption.5 It can be difficult to
obtain IgM autoantibodies in eluates10,15 and in some
early studies all attempts failed.12 An investigation that
addressed these problems showed that heat elution was
the best method,6 and when 42 patients with increased
amounts of cell-bound IgM were examined, IgM was
detected in 38 out of 53 eluates (72%), and its presence
was unrelated to whether the autoantibodies were of
the cold or warm type.6 In another study involving 124
patients with warm-reacting IgA class autoantibodies,
concomitant IgM antibodies were detected in 61 cases
and were elutable in 31.36 IgM was identified in RBC elu-
ates in some10,11,15–17,19,22–26,31 but not all previous
cases.10,11,25 In one instance, the IgM would elute into
albumin or serum but not into saline,32 and in another
report, only when the eluates were tested by a very sen-
sitive radioimmunoassay could IgM be detected.26
Doubts have been expressed30,37 on whether the RBC-
bound IgM found in some series with a high incidence
of this immunoglobulin38,39 was in fact antibody.
However, the results of elution studies6,36 go against this
view and close examination of the papers in ques-
tion38,39 revealed that most patients had cold agglutinin
disease in which it is not unusual to detect IgM autoan-
tibodies on the RBCs if sensitive enzyme-linked methods
are used.6
It was suggested that incomplete warm IgM autoanti-
bodies were possibly 7S monomers.12 This suggestion
was taken up by others,11,14 and, in particular,monomer-
ic IgM was postulated to be the cause of hemolysis in
patients taking methyl dopa therapy.16 This idea attract-
ed considerable attention at the time of publication but
has not been confirmed by later studies.9,40 The molec-
ular size of the autoantibodies was not determined in the
present cases and, in fact, there are only a few reports in
which molecular size has actually been measured. In one
patient with severe autoimmune hemolytic anemia (Hb
73 g/L), the eluted IgM was considered to be monomeric
because it migrated with IgG molecules on an agarose
column.17 In another case, the IgM-coated RBCs of a 49-
year-old woman with severe AIHA (Hb 70 g/L) yielded an
eluate containing 7S low-molecular-weight IgM identified
by analytical ultracentrifugation and double gel diffu-
sion.41 A third patient had the 7S nature of her cold-react-
ing hemolytic antibody demonstrated by Sephadex G-200
gel filtration and density gradient ultracentrifugation.42 In
a larger series, the molecular size of IgM autoantibodies
was investigated in 106 patients with AIHA and increased
amounts of cell-bound IgM (± IgG/IgA).43 IgM, which
would rebind to normal RBCs,was identified in 44 of 106
eluates and subjected to sodium dodecyl sulphate–poly-
acrylamide gel electrophoresis and immunoblotting.The
IgM was pentameric in 43 instances, but in one case, an
elderly patient with chronic lymphocytic leukemia, only
oligomeric IgM was identified.43
In conclusion, warm-type AIHA solely due to IgM-class
autoantibodies is an exceedingly rare condition but should
always be considered when the clinical evidence is in
keeping with this diagnosis and tests have ruled out the
presence of RBC autoantibodies of the IgG and IgA class.
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